Exploring Androgenetic Alopecia in Transgender and Gender-Diverse Populations: Insights on Characterization and Treatment Approaches - Takeaways - MDSpire

Exploring Androgenetic Alopecia in Transgender and Gender-Diverse Populations: Insights on Characterization and Treatment Approaches

  • By

  • Daniel Ramos-Rodriguez

  • Daniel Sanchez-Baez

  • Patricia Cabrera-Garcia

  • Alicia Perez-Bustillo

  • Angela Hermosa-Gelbard

  • Sergio Vaño-Galvan

  • David Saceda-Corralo

  • Juan Jimenez-Cauhe

  • April 1, 2026

  • 0 min

Share

  • 1

    Androgenetic alopecia (AGA) significantly affects quality of life and can exacerbate gender dysphoria in transgender and gender-diverse individuals.

  • 2

    Oral minoxidil is recommended for all individuals with AGA, with dosing tailored to personal therapeutic goals beyond just hair regrowth.

  • 3

    Higher doses of oral minoxidil may be beneficial for transgender men to promote both scalp hair regrowth and desired facial and body hair.

  • 4

    Spironolactone is a first-line antiandrogen for transgender women, while the use of 5-alpha reductase inhibitors requires careful evaluation.

  • 5

    Management recommendations for AGA in transgender populations should be individualized based on gender identity and clinical experience.

Original Source(s)

Related Content